B. BRAUN SE

Company Snapshot

Founded: 1839
Entity Type: Private
Employees: 63011
Region: Germany
Revenue: $9,674 Millions
Revenue Year: 2023
Segment: Hospital Care
Headquarter: Melsungen, Germany
Key Geographics: Europe, Asia-Pacific, Latin America, Middle East and Africa, North America
Corporate Address: Carl-Braun-Straße 1, Melsungen 34212 , Germany Tel. +49-5661-710 www.bbraun.com

Company Overview

B.Braun advances its medical technology and nutritional sectors through new R&D processes. It has more than 300 subsidiaries in 64 countries. It has three divisions: Hospital Care, Aesculap and Avitum.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

B. BRAUN SE In Reports

Disposable Ostomy Bags: Global Market

According to our Research Report the Disposable Ostomy Bags market segmentationsto determine thehistorical (2022), base year(2023) estimated year (2024), and future market status and forecast market growth from 2025 to...

Intravenous (IV) Therapy and Vein Access: Global Markets

BCC Research Report: Dive into intravenous therapy and vein access market report breaks down revenues, while sales figures are estimated for the five years from 2024 through 2029.

Global Diabetic Care Devices Market

BCC Research Report: Dive into diabetes care devices market report aims to provide a comprehensive study of the market Current and historical market revenues can be estimated based on the product type, end user and by...

Company's Business Segments

  • Hospital Care : Hospital Care uses integrated solutions to improve medical care at the hospital and beyond. Our products help give medical professionals more time to care for patients. Our ready-to-use pharmaceutical products and prepared parenteral nutrition in multi-chamber bags help us make clinical processes safer and more efficient. We offer products for the automated production of customized patient medication and nutrition for seriously ill patients, together with software solutions.
  • Aesculap : Our wide range of practical processes for basic surgical and interventional processes help medical professionals provide the best possible care for the patient. In addition, we empower OR professionals to treat patients according to their individual needs using data-centric digital applications. We also offer digitalization solutions for sterile goods management that are adapted to specialists and processes to achieve clinical excellence while lowering costs. With all these integrated solutions, we are driving advancement in the field of surgery and intervention.
  • Avitum : Avitum develops therapy systems for the needs of chronically ill patients. We use integrated solutions to make treatments simple and efficient while also improving quality of life and making work easier for medical professionals. For patients with other chronic conditions—such as chronic wounds, ostomies or urinary incontinence—we are refining our portfolio with products that are reliable and easy to use, even at home. Our focus on infection prevention and control is based on concepts that utilize advice and training to help reduce the risk of infection in all areas of medical treatment, wherever patient care takes place.
  • Other sales

Applications/End User Industries

  • Extracorporeal Blood Purification Therapies
  • Acute Blood Purification
  • Acute Therapies
  • Apheresis Treatment
  • Implantology
  • Sutures
  • Infection Prevention and Control (IPC)
  • Infusion Therapy
  • Fluid and Electrolyte Therapy
  • Vascular Intervention Therapy and Diagnostics
  • Coronary Angioplasty
  • Neurosurgery
  • Gravitational Valves
  • Aneurysm Treatment
  • Nutrition Therapy
  • Oncology
  • Chemotherapy
  • Ostomy
  • Anesthesia
  • Spine Surgery